Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

NCT07403266 is registered in ClinicalTrials.gov with Oils4Cure as lead sponsor.

NCT NCT07403266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07403266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Lead sponsor
Oils4Cure
Phase
Phase 3
Overall status
Recruiting
Start date
June 1, 2024
Completion date
June 30, 2027
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberous sclerosis complex (tsc)